- CEO
- John Michael Johnson
- Full Time Employees
- 5
- Sector
- Industrials
- Industry
- Consulting Services
- Address
- 1111 West 12th Street Las Vegas TX United States of America 78703
- IPO Date
- Sep 26, 2019
- Business
- NEXT-ChemX Corporation (CHMX), a Nevada-based company founded in 2014 and headquartered at 1980 Festival Plaza Drive, Summerlin South 300, Las Vegas, Nevada 89135, develops and commercializes the Ion-Targeting Continuous-Flow Direct Extraction Technology (iTDE Technology), designated as NCX, a novel membrane-based system using high-surface-area hollow fiber membranes that mimics biophysical processes in nature to extract low-concentration ions from liquid solutions at ambient temperatures and pressures without high pressure, temperature, or electrolysis; core applications include lithium extraction from natural brines, geothermal sources, and mine leach solutions such as magnesium, calcium, copper, and nickel; vegetable oil refining by continuously extracting fatty acids; radioactive ion removal of strontium, cesium, and cobalt from nuclear plant waters; metal ion extraction from effluents and tailing ponds; and desalination by ion removal from seawater for pure water production. The company, formerly AllyMe Group Inc. until its name change in July 2021, operates globally with development activities including pilot plant construction in India under contract, targets mining, energy, chemical manufacturing, and water treatment sectors, and serves customers worldwide through scalable, deployable systems demonstrated in laboratory and small commercial pilots. Recent developments encompass the formation of a Nevada LLC partnership with Clontarf Energy plc on February 21, 2024, to commercialize iTDE for lithium extraction from Bolivian brines, with brine samples received for testing and large-scale samples anticipated by October 2024; ongoing construction of two pilot systems—a smaller flexible unit for lithium and other element testing with sensor optimizations, expected completion in Q3 2025, and a larger industrial-scale brine processor—plus nano-filtration integration trials for divalent ion removal; auditor transition from BF Borgers CPA PC to Fruci & Associates II PLLC following SEC actions in May 2024, achieving compliant 2023 10-K/A filing on April 28, 2025, and Q1 2024 10-Q/A on June 30, 2025, amid ongoing reporting efforts; reclassification of its principal intangible iTDE asset to finite life with patent protection-period amortization starting fiscal 2023, carrying value at $2,467,294 as of June 30, 2025; and financing via $495,000 in convertible notes during H1 2025, with total notes payable at $2,080,004 convertible at $1.25 per share, amid a going concern with accumulated deficit of $9.2 million and plans for $3 million raise.